BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Silveira MG, Lindor KD. Clinical features and management of primary sclerosing cholangitis. World J Gastroenterol 2008; 14(21): 3338-3349 [PMID: 18528931 DOI: 10.3748/wjg.14.3338]
URL: https://www.wjgnet.com/1007-9327/full/v14/i21/3338.htm
Number Citing Articles
1
A Zampetti, E Rinninella, R Manna, F Franceschi. Scleroderma and liver disease: a case of an association with primary sclerosing cholangitisScandinavian Journal of Rheumatology 2016; 45(4): 334 doi: 10.3109/03009742.2015.1114667
2
Roger W. Chapman, Kate D. Williamson. Crohn's Disease and Ulcerative Colitis2017; : 531 doi: 10.1007/978-3-319-33703-6_52
3
Maria Teresa A. Seville, Roberto L. Patron, Ann McCullough, Shimon Kusne. Practical Gastroenterology and Hepatology Board Review Toolkit2016; : 487 doi: 10.1002/9781119127437.ch78
4
R. Vialle, S. Velasco, S. Milin, J.-P. Richer, V. Bricot, P.-M. Levillain, J.-P. Tasu. Imagerie des tumeurs bénignes des voies biliaires et de la vésiculeEMC - Radiologie et imagerie médicale - Abdominale - Digestive 2008; 3(4): 1 doi: 10.1016/S1879-8527(08)72832-6
5
Howard C. Masuoka, Raj Vuppalanchi, Ross Deppe, Phelan Bybee, Megan Comerford, Suthat Liangpunsakul, Marwan Ghabril, Naga Chalasani. Individuals with Primary Sclerosing Cholangitis Have Elevated Levels of Biomarkers for Apoptosis but Not NecrosisDigestive Diseases and Sciences 2015; 60(12): 3642 doi: 10.1007/s10620-015-3805-7
6
Gian Andrea Rollandi, Riccardo Piccazzo, Francesco Paparo. Crohn’s Disease2016; : 127 doi: 10.1007/978-3-319-23066-5_14
7
Annika Gauss, Peter Sauer, Adolf Stiehl, Christian Rupp, Johannes Krisam, Yvonne Leopold, Petra Kloeters-Plachky, Wolfgang Stremmel, Daniel Gotthardt. Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing CholangitisMedicine 2016; 95(17): e3510 doi: 10.1097/MD.0000000000003510
8
Erin W. Thackeray, William Sanchez. Practical Gastroenterology and Hepatology: Liver and Biliary Disease2010; : 383 doi: 10.1002/9781444325249.ch36
9
Asher Kornbluth, David B Sachar. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters CommitteeAmerican Journal of Gastroenterology 2010; 105(3): 501 doi: 10.1038/ajg.2009.727
10
Aksana Höblinger, Sven Jonas, Gereon Gäbelein, Tillmann Sauerbruch. Viszeralmedizin2015; : 351 doi: 10.1007/978-3-642-14301-4_24
11
Seth N Sclair, Ester Little, Cynthia Levy. Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisClinical and Translational Gastroenterology 2015; 6(8): e109 doi: 10.1038/ctg.2015.33
12
Sridhar Sundaram, Vaneet Jearth. Primary Sclerosing Cholangitis: A Clinical UpdateEuropean Medical Journal 2019; : 101 doi: 10.33590/emj/10313809
13
Kristel K. Leung, Maya Deeb, Sandra E. Fischer, Aliya Gulamhusein. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future DirectionsSeminars in Liver Disease 2021; 41(03): 409 doi: 10.1055/s-0041-1730950
14
Guillaume Pineton de Chambrun, Maria Nachury, Natalie Funakoshi, Romain Gerard, Michael Bismuth, Jean-Christophe Valats, Fabrizio Panaro, Francis Navarro, Pierre Desreumaux, Benjamin Pariente, Pierre Blanc. Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitisEuropean Journal of Gastroenterology & Hepatology 2018; 30(10): 1247 doi: 10.1097/MEG.0000000000001223
15
Marina G Silveira, Natalie J Torok, Andrea A Gossard, Jill C Keach, Roberta A Jorgensen, RN, Janice L Petz, RN, Keith D Lindor. Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot StudyThe American Journal of Gastroenterology 2009; 104(1): 83 doi: 10.1038/ajg.2008.14
16
Peter Fickert, Andrea Thueringer, Tarek Moustafa, Dagmar Silbert, Judith Gumhold, Oleksiy Tsybrovskyy, Margitta Lebofsky, Hartmut Jaeschke, Helmut Denk, Michael Trauner. The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in miceLaboratory Investigation 2010; 90(6): 844 doi: 10.1038/labinvest.2010.61
17
S. Segato, I. Arena. An unusual association of rare diseasesJournal of Medicine and the Person 2010; 8(2): 78 doi: 10.1007/s12682-010-0048-4
18
Takahiro Tsuchikawa, Satoshi Kondo, Satoshi Hirano, Eiichi Tanaka, Kentaro Kato, Joe Matsumoto, Kanako C. Kubota, Toshiaki Shichinohe. Extensively spreading intraepithelial bile duct carcinoma causing multiple bile duct strictures: Report of three casesSurgery Today 2011; 41(12): 1674 doi: 10.1007/s00595-011-4508-0
19
Emmanouil Sinakos, Hanns-Ulrich Marschall, Kris V. Kowdley, Alex Befeler, Jill Keach, Keith Lindor. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progressionHepatology 2010; 52(1): 197 doi: 10.1002/hep.23631
20
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseasesJournal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
21
Ian R. Mackay. Clustering and commonalities among autoimmune diseasesJournal of Autoimmunity 2009; 33(3-4): 170 doi: 10.1016/j.jaut.2009.09.006
22
Kidist K. Yimam, Christopher L. Bowlus. Diagnosis and classification of primary sclerosing cholangitisAutoimmunity Reviews 2014; 13(4-5): 445 doi: 10.1016/j.autrev.2014.01.040
23
Andrea Tringali, Vincenzo Bove, Guido Costamagna. Endoscopic approach to benign biliary obstructionGastrointestinal Intervention 2015; 4(1): 1 doi: 10.1016/j.gii.2015.04.001
24
Emmanouil Sinakos, Sunil Samuel, Felicity Enders, Edward V. Loftus, William J. Sandborn, Keith D. Lindor. Inflammatory Bowel Disease in Primary Sclerosing CholangitisInflammatory Bowel Diseases 2013; 19(5): 1004 doi: 10.1097/MIB.0b013e3182802893
25
Josiah D. McCain, David M. Chascsa, Keith D. Lindor. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patientsExpert Opinion on Orphan Drugs 2021; 9(2): 53 doi: 10.1080/21678707.2021.1898370
26
Werner Van Steenbergen, Lieve Braeye, Rudy Harlet, Frederik Nevens, Johan Fevery, Valeer Desmet, Tania Roskams, Jacques Pirenne. Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantationEuropean Journal of Gastroenterology & Hepatology 2010; 22(10): 1265 doi: 10.1097/MEG.0b013e32833dbd81
27
Cyriac Abby Philips, Philip Augustine, Nikhil Phadke. Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis – A Single Case ReportJournal of Clinical and Translational Hepatology 2018; 6(xx): 1 doi: 10.14218/JCTH.2018.00033
28
Vincenzo Perri, Pietro Familiari, Andrea Tringali, Ivo Boskoski, Guido Costamagna. Plastic Biliary Stents for Benign Biliary DiseasesGastrointestinal Endoscopy Clinics of North America 2011; 21(3): 405 doi: 10.1016/j.giec.2011.04.012
29
Hiroaki Sawai, Hiroyuki Matsubayashi, Keiko Sasaki, Masaki Tanaka, Naomi Kakushima, Kohei Takizawa, Yuichiro Yamaguchi, Hiroyuki Ono. A Case of Sclerosing Cholangitis without Pancreatic Involvement Thought to be Associated with AutoimmunityInternal Medicine 2011; 50(5): 433 doi: 10.2169/internalmedicine.50.4471
30
Gary C. Kanel. Atlas of Liver Pathology2024; : 74 doi: 10.1016/B978-0-323-82533-7.00004-1
31
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra, Martina Gambato. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance StrategiesCancers 2023; 15(20): 4947 doi: 10.3390/cancers15204947
32
Roberta E. Rossi, Dario Conte, Sara Massironi. Primary sclerosing cholangitis associated with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2016; 28(2): 123 doi: 10.1097/MEG.0000000000000532
33
Jocelyn Trottier, Andrzej Białek, Patrick Caron, Robert J. Straka, Jenny Heathcote, Piotr Milkiewicz, Olivier Barbier. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot studyDigestive and Liver Disease 2012; 44(4): 303 doi: 10.1016/j.dld.2011.10.025
34
Kimchi Nguyen, Charlotte D’Mello, Tai Le, Stefan Urbanski, Mark G. Swain. Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic miceJournal of Hepatology 2012; 56(3): 626 doi: 10.1016/j.jhep.2011.09.014
35
Amber G. Bozward, Vincenzo Ronca, Daniel Osei-Bordom, Ye Htun Oo. Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational TherapyFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.711217
36
Vanja Giljaca, Goran Poropat, Davor Stimac, Christian Gluud. Glucocorticosteroids for primary sclerosing cholangitisCochrane Database of Systematic Reviews 2010;  doi: 10.1002/14651858.CD004036.pub3
37
Andreas E Kremer, Christian Rust, Peter Eichhorn, Ulrich Beuers, Stefan Holdenrieder. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markersExpert Review of Molecular Diagnostics 2009; 9(2): 139 doi: 10.1586/14737159.9.2.139
38
John Halliday, Roger W. Chapman. Crohn's Disease and Ulcerative Colitis2012; : 579 doi: 10.1007/978-1-4614-0998-4_47
39
Tim Fulmer. A TRAIL in liver diseaseScience-Business eXchange 2008; 1(26): 615 doi: 10.1038/scibx.2008.615
40
Hiroyuki Matsubayashi, Kimihiro Igarashi, Yoshihiro Kishida, Yukio Yoshida, Keiko Sasaki, Hiroyuki Ono. Sclerosing cholangitis with thumbprint appearance and incomplete steroid responseJournal of Digestive Diseases 2014; 15(10): 578 doi: 10.1111/1751-2980.12176
41
Gary C. Kanel, Jacob Korula. Atlas of Liver Pathology2011; : 52 doi: 10.1016/B978-1-4377-0765-6.10003-5
42
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel diseaseExpert Review of Gastroenterology & Hepatology 2009; 3(6): 681 doi: 10.1586/egh.09.53
43
Maria Teresa A. Seville, Ann McCullough, Shimon Kusne. Practical Gastroenterology and Hepatology: Liver and Biliary Disease2010; : 200 doi: 10.1002/9781444325249.ch20